Info@ThinkPinkRocks.com

Anthracycline-based breast cancer chemotherapy linked to neurotoxicity

Breast cancer patients treated with anthracycline-based chemotherapy regimens may be at greater risk of neurocognitive problems than those given nonanthracycline regimens, indicate findings.

See original article:
Anthracycline-based breast cancer chemotherapy linked to neurotoxicity

Share

Leave a Reply

Solve : *
4 + 16 =